ARTTX
Price
$25.37
Change
+$0.21 (+0.83%)
Updated
Jul 17 closing price
Net Assets
1.22B
GFACX
Price
$70.96
Change
+$0.29 (+0.41%)
Updated
Jul 16 closing price
Net Assets
323.95B
Interact to see
Advertisement

ARTTX vs GFACX

Header iconARTTX vs GFACX Comparison
Open Charts ARTTX vs GFACXBanner chart's image
Artisan Focus Fund Investor
Price$25.37
Change+$0.21 (+0.83%)
VolumeN/A
Net Assets1.22B
American Funds Growth Fund of Amer C
Price$70.96
Change+$0.29 (+0.41%)
VolumeN/A
Net Assets323.95B
ARTTX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARTTX vs. GFACX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARTTX is a StrongBuy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 324B vs. ARTTX (1.22B). ARTTX (0.00) and GFACX (0.00) have matching dividends . ARTTX was incepted earlier than GFACX: ARTTX (8 years) vs GFACX (24 years). GFACX (1.36) and ARTTX (1.30) have similar cost to investors . ARTTX is a more actively managed with annual turnover of: 401.50 vs. GFACX (25.00). GFACX has a lower initial minimum investment than ARTTX: GFACX (250) vs ARTTX (1000). ARTTX annual gain was more profitable for investors over the last year : 14.64 vs. GFACX (7.11). ARTTX return over 5 years is better than : 45.47 vs. GFACX (35.91).
ARTTXGFACXARTTX / GFACX
Total Expense Ratio1.301.3696%
Annual Report Gross Expense Ratio1.301.3696%
Fund Existence8 years24 years-
Gain YTD18.11011.292160%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.22B324B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year14.647.11206%
Returns for 3 years57.3852.01110%
Returns for 5 years45.4735.91127%
Returns for 10 yearsN/A63.31-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.860.06
+3.33%
Inhibikase Therapeutics
MKC71.380.63
+0.89%
McCormick & Company
VTS22.940.06
+0.26%
Vitesse Energy
ADN1.95N/A
N/A
Advent Technologies Holdings Inc.
BTE1.84-0.04
-2.13%
Baytex Energy Corp